111 related articles for article (PubMed ID: 11867016)
1. Changing trends in cytomegalovirus disease in HIV-infected patients.
Deayton JR
Herpes; 2001 Jul; 8(2):37-40. PubMed ID: 11867016
[TBL] [Abstract][Full Text] [Related]
2. [CMV infection in HIV-infected patients].
Podlasin RB
Przegl Epidemiol; 2007; 61(4):629-37. PubMed ID: 18572494
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).
Steininger C; Puchhammer-Stöckl E; Popow-Kraupp T
J Clin Virol; 2006 Sep; 37(1):1-9. PubMed ID: 16675299
[TBL] [Abstract][Full Text] [Related]
4. The changing pattern of cytomegalovirus retinitis in human immunodeficiency virus disease.
Au Eong KG; Beatty S; Charles SJ
Singapore Med J; 2000 Jun; 41(6):298-300. PubMed ID: 11109349
[TBL] [Abstract][Full Text] [Related]
5. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
8. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
9. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
Johnson SC; Benson CA; Johnson DW; Weinberg A
Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
[TBL] [Abstract][Full Text] [Related]
11. Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy.
Baldanti F; Paolucci S; Parisi A; Meroni L; Gerna G
Clin Infect Dis; 2002 Apr; 34(8):1146-9. PubMed ID: 11915006
[TBL] [Abstract][Full Text] [Related]
12. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity.
Springer KL; Weinberg A
J Antimicrob Chemother; 2004 Sep; 54(3):582-6. PubMed ID: 15282241
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic infections: an update.
Furrer H; Fux C
J HIV Ther; 2002 Feb; 7(1):2-7. PubMed ID: 11956497
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
16. Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.
French M; Price P
J HIV Ther; 2002 May; 7(2):46-51. PubMed ID: 12553688
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).
Erice A; Tierney C; Hirsch M; Caliendo AM; Weinberg A; Kendall MA; Polsky B;
Clin Infect Dis; 2003 Aug; 37(4):567-78. PubMed ID: 12905142
[TBL] [Abstract][Full Text] [Related]
18. CMV as a cofactor enhancing progression of AIDS.
Griffiths PD
J Clin Virol; 2006 Apr; 35(4):489-92. PubMed ID: 16413825
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment.
Stone SF; Price P; Tay-Kearney ML; French MA
J Infect Dis; 2002 Jun; 185(12):1813-7. PubMed ID: 12085331
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
